Search results for "From ACP Journal Club"


 
Results 91 - 100 of about 129 for "From ACP Journal Club".

Review: Bariatric surgery improves weight and glycemia in nonmorbidly obese adults with diabetes | ACP Diabetes Monthly

A review of 3 randomized controlled trials found that surgical treatment increased weight loss and improved diabetes-related outcomes more than nonsurgical treatment in moderately obese patients.

Some antimicrobials increased admissions and ED visits for hypoglycemia in older users of glipizide or glyburide | ACP Diabetes Monthly

A study of Texas Medicare patients who took either glipizide or glyburide found that those who were also prescribed certain antibiotics had a much higher rate of hypoglycemic events than those taking an antibiotic not expected to interact with

Gastric bypass or biliopancreatic diversion increases remission from type 2 diabetes in obese adults | ACP Diabetes Monthly

A randomized controlled trial (RCT) of 60 severely obese adults with type 2 diabetes found that gastric bypass or biliopancreatic diversion increased diabetes remission more than medical therapy.

Bariatric surgery improved HbA1c more than intensive medical therapy in obese patients with uncontrolled type 2 DM | ACP Diabetes Monthly

Longer-term outcomes show that adding Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy to intensive medical therapy enabled more obese, type 2 diabetes patients to maintain glycemic control.

In overweight or obese patients with diabetes, a lifestyle intervention increased weight loss at 8 years | ACP Diabetes Monthly

Receiving an intensive lifestyle intervention (ILI) rather than traditional diabetes support and education (DSE) increased weight loss in about 5,000 middle-aged adults with type 2 diabetes.

Metformin reduced CV events compared with glipizide in patients with type 2 diabetes and CAD | ACP Diabetes Monthly

A multicenter randomized controlled trial of Chinese patients with type 2 diabetes and coronary artery disease found that metformin reduced cardiovascular events more than glipizide at 5 years.

October 12, 2012 | ACP Diabetes Monthly

ACP Diabetes Monthly delivers a monthly summary of news about diabetes, including the latest research, clinical guidelines, and FDA drug actions.

January 12, 2018 | ACP Diabetes Monthly

ACP Diabetes Monthly delivers a monthly summary of news about diabetes, including the latest research, clinical guidelines, and FDA drug actions.

Adding lisinopril to losartan increased hyperkalemia and acute kidney injury in type 2 diabetes and proteinuria | ACP Diabetes Monthly

In a trial of more than 1,000 diabetic patients with proteinuria, adding an ACE inhibitor to an ARB didn't improve estimated glomerular filtration rate and increased risk for hyperkalemia and acute kidney injury, so the trial was halted early.

Review: In diabetes with multivessel or left main CAD, PCI increases death/MI/stroke combo compared with CABG | ACP Diabetes Monthly

In patients with diabetes and multivessel disease or left main coronary artery disease (CAD), percutaneous coronary intervention (PCI) was associated with a higher rate of death, myocardial infarction (MI), or stroke than coronary artery bypass

Result Page: Prev   5   6   7   8   9   10   11   12   13   Next